Entrada Therapeutics (TRDA) Non-Current Assets (2020 - 2026)
Entrada Therapeutics (TRDA) recorded Non-Current Assets of $66.17 million in Q2 2026, down 16.9% from $79.64 million a year earlier and down 3.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics reported Non-Current Assets of $71.13 million, down 17.6% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 81.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $86.28 million in FY2024 (-13.2%), $99.42 million in FY2023 (+135.7%), $42.18 million in FY2022 (+491.4%) and $7.13 million in FY2021 (+99.4%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2023.
- On a year-over-year basis, Non-Current Assets has declined for nine consecutive quarters, with an average decline of 15.2% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 491.4% in Q4 2022, against a decline of 17.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $68.65 million (Q1 2026), $71.13 million (Q4 2025) and $74.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - | 63.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 63.93 Mn |
| Jun 30, 2026 | 66.17 Mn |
| Mar 31, 2026 | 68.65 Mn |
| Dec 31, 2025 | 71.13 Mn |
| Sep 30, 2025 | 74.64 Mn |
| Jun 30, 2025 | 79.64 Mn |
| Mar 31, 2025 | 83.29 Mn |
| Dec 31, 2024 | 86.28 Mn |
| Sep 30, 2024 | 89.26 Mn |
| Jun 30, 2024 | 92.43 Mn |
| Mar 31, 2024 | 96.67 Mn |
| Dec 31, 2023 | 99.42 Mn |
| Sep 30, 2023 | 101.99 Mn |
| Jun 30, 2023 | 103.79 Mn |
| Mar 31, 2023 | 41.43 Mn |
| Dec 31, 2022 | 42.18 Mn |
| Sep 30, 2022 | 39.73 Mn |
| Jun 30, 2022 | 42.01 Mn |
| Mar 31, 2022 | 43.99 Mn |
| Dec 31, 2021 | 7.13 Mn |
API Access
Entrada Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();